BR9509276A - Processos para produzir uma bactéria entérica testar um agente antimicrobiano potencial detectar anticorpos de um hospedeiro para bactéria enterica e bactéria enterica em um animal ou amostra biologica deste produzir anticorpos antibacterianos e estimular uma imuno-resposta em um animal bactéria entérica tendo propriedades antigênicas aumentadas vacina e estojo de teste diagnostico para detectar um hospediro de anticorpos para bacteria enterica ou para detectar bactéria enterica - Google Patents

Processos para produzir uma bactéria entérica testar um agente antimicrobiano potencial detectar anticorpos de um hospedeiro para bactéria enterica e bactéria enterica em um animal ou amostra biologica deste produzir anticorpos antibacterianos e estimular uma imuno-resposta em um animal bactéria entérica tendo propriedades antigênicas aumentadas vacina e estojo de teste diagnostico para detectar um hospediro de anticorpos para bacteria enterica ou para detectar bactéria enterica

Info

Publication number
BR9509276A
BR9509276A BR9509276A BR9509276A BR9509276A BR 9509276 A BR9509276 A BR 9509276A BR 9509276 A BR9509276 A BR 9509276A BR 9509276 A BR9509276 A BR 9509276A BR 9509276 A BR9509276 A BR 9509276A
Authority
BR
Brazil
Prior art keywords
enteric bacteria
detect
antibodies
enteric
host
Prior art date
Application number
BR9509276A
Other languages
English (en)
Portuguese (pt)
Inventor
John L Pace
Richard Ian Walker
Steven M Frey
Original Assignee
Antex Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,543 external-priority patent/US5681736A/en
Application filed by Antex Biolog Inc filed Critical Antex Biolog Inc
Publication of BR9509276A publication Critical patent/BR9509276A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/107—Vibrio
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045—Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9509276A 1994-10-05 1995-10-04 Processos para produzir uma bactéria entérica testar um agente antimicrobiano potencial detectar anticorpos de um hospedeiro para bactéria enterica e bactéria enterica em um animal ou amostra biologica deste produzir anticorpos antibacterianos e estimular uma imuno-resposta em um animal bactéria entérica tendo propriedades antigênicas aumentadas vacina e estojo de teste diagnostico para detectar um hospediro de anticorpos para bacteria enterica ou para detectar bactéria enterica BR9509276A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
PCT/US1995/013196 WO1996011258A1 (fr) 1994-10-05 1995-10-04 Procedes de production de bacteries enteriques antigenes ameliorees et vaccins les contenant

Publications (1)

Publication Number Publication Date
BR9509276A true BR9509276A (pt) 1997-11-18

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509276A BR9509276A (pt) 1994-10-05 1995-10-04 Processos para produzir uma bactéria entérica testar um agente antimicrobiano potencial detectar anticorpos de um hospedeiro para bactéria enterica e bactéria enterica em um animal ou amostra biologica deste produzir anticorpos antibacterianos e estimular uma imuno-resposta em um animal bactéria entérica tendo propriedades antigênicas aumentadas vacina e estojo de teste diagnostico para detectar um hospediro de anticorpos para bacteria enterica ou para detectar bactéria enterica

Country Status (16)

Country Link
EP (1) EP0804542A4 (fr)
JP (1) JP3394047B2 (fr)
CN (1) CN1168693A (fr)
AU (1) AU704283B2 (fr)
BR (1) BR9509276A (fr)
CA (1) CA2202027A1 (fr)
CZ (1) CZ104397A3 (fr)
FI (1) FI971403L (fr)
HU (1) HUT77876A (fr)
IL (1) IL115521A0 (fr)
MX (1) MX9702431A (fr)
NO (1) NO971519L (fr)
NZ (1) NZ295907A (fr)
PL (1) PL182700B1 (fr)
SG (2) SG73509A1 (fr)
WO (1) WO1996011258A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255064T3 (es) * 1994-10-05 2006-06-16 Emergent Immunosolutions Inc. Procedimientos de produccion de helicobacter sp antigenico potenciado y vacunas que comprenden el mismo.
CN102304527A (zh) * 2003-05-30 2012-01-04 英特塞尔股份公司 肠球菌抗原
WO2007108903A2 (fr) * 2006-03-17 2007-09-27 Cerebus Biologicals, Inc. Vaccins contre campylobacter et procedes d'utilisation
EP2161035B1 (fr) * 2007-05-28 2019-08-21 Daiichi Sankyo Company, Limited Composition de vaccin à cellules entières contenant bordetella parapertussis
CN107513553B (zh) * 2017-09-18 2021-05-18 江南大学 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法
CN109633151B (zh) * 2018-12-26 2022-03-11 西北农林科技大学 一种肠炎沙门氏菌检测方法、试纸条及应用
US12403187B2 (en) 2018-12-31 2025-09-02 Bellevacc As Bacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06503231A (ja) * 1991-09-18 1994-04-14 アムジエン・インコーポレーテツド 胆汁酸塩を含有するｂ型肝炎ワクチン製剤

Also Published As

Publication number Publication date
NO971519L (no) 1997-05-27
HUT77876A (hu) 1998-09-28
EP0804542A4 (fr) 1998-10-28
PL319580A1 (en) 1997-08-18
SG73510A1 (en) 2000-06-20
EP0804542A1 (fr) 1997-11-05
CN1168693A (zh) 1997-12-24
JPH10507347A (ja) 1998-07-21
FI971403A0 (fi) 1997-04-04
IL115521A0 (en) 1996-06-18
SG73509A1 (en) 2000-06-20
PL182700B1 (pl) 2002-02-28
JP3394047B2 (ja) 2003-04-07
FI971403A7 (fi) 1997-06-04
CZ104397A3 (cs) 1998-06-17
NO971519D0 (no) 1997-04-03
AU3956195A (en) 1996-05-02
NZ295907A (en) 1999-04-29
WO1996011258A1 (fr) 1996-04-18
AU704283B2 (en) 1999-04-15
MX9702431A (es) 1998-05-31
CA2202027A1 (fr) 1996-04-18
FI971403L (fi) 1997-06-04

Similar Documents

Publication Publication Date Title
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
DE68923932D1 (de) Hauttest und Testkit für AIDS.
BR0112602A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
Wood et al. Distribution of persistent Salmonella typhimurium infection in internal organs of swine
BR9916020A (pt) Compostos e métodos para o tratamento e diagnóstico de infecção por chlamydia
DE69130986D1 (de) Rotoren für die Analytik und Verfahren zur Analyse biologischer Fluide
DE69531743D1 (de) System und verfahren zur diagnose von krankheiten an lebendem gewebe
BR9507502A (pt) Formulação de tablete processo de tratamento de infecções bacteriais em seres humanos ou em animais processo para preparação de uma formulação de tablete uso de uma formulação de tablete e processo de tratamento de uma infeção bacterial em um paciente humano
DE69121290D1 (de) Methode zur Bestimmung von Antikörper gegen Chlamydia Trachomatis und diagnostisches Präparat für Chlamydia Trachomatis-Infektion
Derakhshanfar et al. A study on avian cellulitis in broiler chickens.
BR9710173A (pt) Processo de preparação de dna utilizável em terapia gênica utilização de um dna plasmático para a preparaç~o de uma composição farmacêutica destinada ao tratamento terapêutico ou ao diagnóstico do corpo humano ou animal processo de preparação desta composição farmacêutica e composição compreendendo um dna bacteriano
WO2000000615A3 (fr) COMPOSES ET PROCEDES SERVANT A DIAGNOSTIQUER ET A TRAITER L'INFECTION PAR $i(EHRLICHIA)
Gadberry et al. Pasteurella pneumotropica isolated from bone and joint infections
BR9509275A (pt) Processos para produzir bactéria helicobacter tendo propriedades antigênicas aumentadas testar um agente antimicrobiano potencial detectar anticorpos de um hospedeiro para bactéria helicobacter e bactéria helicobacter em um animal ou amostra biológica deste produzir anticorpos antibacterianos e estimular e estimular uma imunoresposta em um animal bactéria helicobacter vacina e estojo de teste diagnóstico para detectar um hospedeiro de anticorpos para bactéria helicobacter ou para detectar bactéria helicobacter
DE69312309D1 (de) Verdichtungsprüfung zur bewertung einer therapie für eine atmungskrankheit
McFarland et al. Profiles of toxin production by thermophilic Campylobacter of animal origin
BR9801685A (pt) Mutante de birnavírus birnavírus vacina contra uma infecção por birnavírus em animais processo para determinar uma infecção por birnavírus em um animal kit de teste diagnóstico e uso da falta de expressão de proteína vp5 nativa por um mutante de birnavírus
FR2802213B1 (fr) Bacterie "rickettsia pulicis" methode d'isolement en culture et de diagnostic serologique
Hussaini et al. Studies on Escherichia coli vaccines: Estimation of endotoxins in veterinary vaccines
BR9706543A (pt) Serpens spp biologicamente pura cepa hbl-112, composição farmacêutica e processos para evitar e/ou tratar dermatite digital papilomatosa de ruminante, e para determinar a presença de anticorpos pdd em uma amostra de soro e de anticorpos anti-serpens spp. em um ruminante, e, kit de diagnóstico
Young A stain for demonstrating Helicobacter pylori in gastric biopsies
Zimmerli et al. Pus potassium
Champlin et al. Low propensity for poultry isolates of Pasteurella multocida to acquire adaptive resistance to oxytetracycline
PT809653E (pt) Anigenio de helicobacter pylori
RU95110283A (ru) Способ идентификации бактерий

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO, TENDO POR BASE O ARTIGO 10 INCISO IX E ARTIGO 25 DA LPI 9.279 DE 14/05/96 E ART. 229-A DA LEI 10.196 DE 14/02/01.